KinetiCor, Inc., secured FDA clearance for system used on Siemens Healthineers MRI Scanner.
KinetiCor, Inc., the only approved manufacturer of optical motion detection solutions for MRI scanners, received 510(k) clearance from the U.S. Food and Drug Administration Wednesday for its Motion Correction System.
This system is approved for use as an accessory to the Siemens Healthineers MAGNETOM Skyra 3T MRI scanner, and it uses sensor-based technology to track patient movement during an MRI scan. According to a company release, it provides the current patient position in real-time to the MRI scanner, allowing for further data processing. The system adjusts images as needed, offering head-pose tracking and correction within six degree of freedom for MR applications.
“During a neurological MRI, it’s difficult for a patient’s head to remain perfectly still, often leading to discomfort for the patient and, likewise, often rendering the resulting images to be unclear and lacking sharpness,” said Doug Donzelli, KinetiCor chief executive officer. “MRI degradation can prevent physicians from effectively analyzing MRI images and can frequently require that additional scans be performed.”
To counteract this issue in the Skyra 3T MRI scanner, he said, KinetiCor’s image correction software can identify inadvertent movement during the scanning process. The goal is to potentially reduce repeated MRI scans, saving hospitals, physicians, and insurers money each year.
This FDA approval is part of an ongoing innovation partnership with Siemens Healthineers, said KinetiCor’s chairman and chief technology officer Jeffrey Yu, M.D.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.